ProCE Banner Activity

Integrating New Data on HIV Adverse Events From IAS 2023: Pharmacist Perspectives

Podcast Episodes

Listen as pharmacist experts Brooke Bates, PharmD, BCPS, AAHIVP, and Neha Sheth Pandit, PharmD, AAHIVP, BCPS, discuss the most clinically relevant studies on HIV adverse events presented at IAS 2023, with a special focus on cardiovascular risk and weight considerations with ART.

Released: September 15, 2023

Share

Faculty

Brooke Bates

Brooke Bates, PharmD, BCPS, AAHIVP

Specialty Pharmacy Clinical Manager
Pediatric HIV Clinical Pharmacist
Indiana University Health
Indianapolis, Indiana

Princy N Kumar

Princy N Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Jeffrey Kwong

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN, AAHIVS, ACRN

Professor, Division of Advanced Nursing Practice
Rutgers, The State University of New Jersey
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Neha Sheth Pandit

Neha Sheth Pandit, PharmD, AAHIVP, BCPS

Professor
Vice Chair for Research and Scholarship
Department of Practice, Sciences, and Health Outcomes Research
School of Pharmacy
University of Maryland
Clinical Pharmacist
THRIVE Program
Baltimore, Maryland

Nimish Patel

Nimish Patel, PharmD, PhD, AAHIVP

Professor of Clinical Pharmacy
Skaggs School of Pharmacy & Pharmaceutical Sciences
University of California, San Diego
La Jolla, California

Provided by

Provided by Clinical Care Options, LLC, in partnership with the American Academy of HIV Medicine (AAHIVM)

ProCE Banner

Supporters

Supported by an educational grant from Viiv Healthcare

ViiV Healthcare

Partners

AAHIVM

ProCE Banner

Program Director Disclosure

Program Director

Princy N Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Princy N. Kumar, MD, FIDSA, MACP: consultant/advisor/speaker: Gilead Sciences, Johnson & Johnson, Merck, Theratechnologies, ViiV; researcher: American Gene Technologies, Gilead Sciences, GlaxoSmithKline, Merck; stock/stock options: Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN, AAHIVS, ACRN

Professor, Division of Advanced Nursing Practice
Rutgers, The State University of New Jersey
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN, AAHIVS, ACRN, has no relevant financial relationships to disclose.

Nimish Patel, PharmD, PhD, AAHIVP

Professor of Clinical Pharmacy
Skaggs School of Pharmacy & Pharmaceutical Sciences
University of California, San Diego
La Jolla, California

Nimish Patel, PharmD, PhD, AAHIVP: researcher: Gilead, Janssen.

Faculty Disclosure

Primary Author

Brooke Bates, PharmD, BCPS, AAHIVP

Specialty Pharmacy Clinical Manager
Pediatric HIV Clinical Pharmacist
Indiana University Health
Indianapolis, Indiana

Brooke Bates, PharmD, BCPS, AAHIVP, has no relevant financial relationships to disclose.

Neha Sheth Pandit, PharmD, AAHIVP, BCPS

Professor
Vice Chair for Research and Scholarship
Department of Practice, Sciences, and Health Outcomes Research
School of Pharmacy
University of Maryland
Clinical Pharmacist
THRIVE Program
Baltimore, Maryland

Neha Sheth Pandit, PharmD, AAHIVP, BCPS: researcher: Theratechnologies.